Maria Mesuraca
Overview
Explore the profile of Maria Mesuraca including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
35
Citations
646
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Mesuraca M, Quaresima B, Scicchitano S, Faniello M
Int J Mol Sci
. 2025 Mar;
26(5).
PMID: 40076503
Mammalian cells can obtain energy by taking up different macromolecules, depending on their availability in the external environment [...].
2.
Quaresima B, Scicchitano S, Faniello M, Mesuraca M
Int J Mol Med
. 2024 Nov;
55(2).
PMID: 39611477
Solute carrier (SLC) transporters are involved in various biological processes associated with metabolic reprogramming and cancer, supporting the increased requirement of nutrients and energy. Over the past decade, there have...
3.
Scicchitano S, Faniello M, Mesuraca M
Int J Mol Sci
. 2023 Oct;
24(19).
PMID: 37834202
The human zinc finger protein 521 (ZNF521) is a co-transcriptional factor with multiple recognized regulatory functions in a range of normal, cancer and stem cell compartments. ZNF521 regulates proliferation, progression...
4.
Gallo Cantafio M, Torcasio R, Scionti F, Mesuraca M, Ronchetti D, Pistoni M, et al.
Cells
. 2023 Sep;
12(18).
PMID: 37759449
G protein-coupled estrogen receptor 1 (GPER1) activation is emerging as a promising therapeutic strategy against several cancer types. While GPER targeting has been widely studied in the context of solid...
5.
Editorial to the Special Issue "Recent Advances in Biochemical Mechanisms of Acute Myeloid Leukemia"
Mesuraca M, Nistico C, Chiarella E
Biomedicines
. 2023 May;
11(5).
PMID: 37239010
Acute myeloid leukemia (AML) is a clonal malignant disorder of myeloid progenitor cells characterized by uncontrolled proliferation, dysregulation in the differentiation program, and inhibition of apoptosis mechanisms [...].
6.
Di Vito A, Bria J, Antonelli A, Mesuraca M, Barni T, Giudice A, et al.
Int J Mol Sci
. 2023 May;
24(9).
PMID: 37175504
Periodontitis is a gingiva disease sustained by microbially associated and host-mediated inflammation that results in the loss of the connective periodontal tissues, including periodontal ligament and alveolar bone. Symptoms include...
7.
Mesuraca M, Nistico C, Lombardo N, Piazzetta G, Lobello N, Chiarella E
Int J Mol Sci
. 2022 Nov;
23(21).
PMID: 36362001
Killian's (antrochoanal) polyp is a unilateral nasal polypoid lesion of the maxillary sinus especially affecting children and young adults with unilateral nasal obstruction, pus discharge, and headache. Although its etiology...
8.
Scicchitano S, Montalcini Y, Lucchino V, Melocchi V, Gigantino V, Chiarella E, et al.
PLoS One
. 2022 Oct;
17(10):e0274785.
PMID: 36191006
Epithelial ovarian carcinoma (EOC) is the most lethal gynecological tumor, that almost inevitably relapses and develops chemo-resistance. A better understanding of molecular events underlying the biological behavior of this tumor,...
9.
Chiarella E, Nistico C, Di Vito A, Morrone H, Mesuraca M
Biomedicines
. 2022 May;
10(5).
PMID: 35625883
Metabolic reprogramming represents a hallmark of tumorigenesis to sustain survival in harsh conditions, rapid growth and metastasis in order to resist to cancer therapies. These metabolic alterations involve glucose metabolism,...
10.
Chiarella E, Aloisio A, Scicchitano S, Todoerti K, Cosentino E, Lico D, et al.
Int J Mol Sci
. 2021 Oct;
22(19).
PMID: 34639154
Leukemias derived from the MLL-AF9 rearrangement rely on dysfunctional transcriptional networks. ZNF521, a transcription co-factor implicated in the control of hematopoiesis, has been proposed to sustain leukemic transformation in collaboration...